Back to Trades
Total Value
$5.6M
Filing Date
Jul 10, 2026
2 transactions
Trade Summary
On Jul 9, 2026, Mistras Theodora, CVP, Chief Financial Officer, reported $5.6M of Edwards Lifesciences Corp (EW) across 2 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $91.33. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Edwards Lifesciences Corp
- Ticker Symbol
- EW
- CIK
- 0001099800
Insider Information
- Name
- Mistras Theodora
- Role
- CVP, Chief Financial Officer
- Location
- IRVINE, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 9, 2026
- Accession Number
- 0001225208-26-006578
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | 87,595 | — | Grant/Award | — |
| Jul 9, 2026 | Common Stock | 12,325 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | EW derivative | 61,800 | $91.33 | Grant/Award | $5.6M |
| Jul 9, 2026 | EW derivative | 12,325 | — | Grant/Award | — |
Want live alerts when Mistras Theodora trades again?
Download Insider Trades to track EW, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the "Start Date"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date.
- (F2)These restricted stock units were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- (F3)These options were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- (F4)Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.